華潤三九(000999.SZ):飲片業務長期將聚焦重點藥材資源進行全產業鏈佈局和發展
格隆匯6月14日丨華潤三九(000999.SZ)召開電話會議,就“飲片業務未來定位和發展?”
公司回覆稱,考慮到飲片和配方顆粒業務在生產和終端推廣上有非常好的協同性,公司於2020年開始佈局飲片業務。去年由於國標切換,配方顆粒業務部分地區銷售困難,飲片的推廣力度有所增加。未來公司將以配方顆粒業務為主,飲片業務作為補充。飲片業務長期將聚焦重點藥材資源進行全產業鏈佈局和發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.